StockWatch
·
Biotechnology: Pharmaceutical Preparations
SplitJul 7, 2026, 08:07 AM

Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9

AI Summary

Enlivex Ltd. announced a 1-for-15 reverse stock split of its ordinary shares, effective July 9, 2026. This action will combine every 15 ordinary shares into one, reducing the number of authorized shares from 2,375,000,000 to 158,333,334 and issued/outstanding shares from 252,480,222 to approximately 16,832,015. The par value will increase from NIS 0.40 to NIS 6.00, and fractional shares will be rounded up.

Key Highlights

  • Enlivex will implement a 1-for-15 reverse stock split.
  • The reverse split will be effective on July 9, 2026.
  • Authorized ordinary shares will decrease from 2,375,000,000 to 158,333,334.
  • Issued and outstanding shares will decrease from 252,480,222 to approximately 16,832,015.
  • Par value per share will increase from NIS 0.40 to NIS 6.00.
  • Fractional shares will be rounded up to the nearest whole ordinary share.
  • The company's ordinary shares will continue to trade under the symbol "ENLV" on Nasdaq.